Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.
Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF. Liu C, et al. Among authors: fridkin sk. Clin Infect Dis. 2011 Feb 1;52(3):285-92. doi: 10.1093/cid/cir034. Clin Infect Dis. 2011. PMID: 21217178
Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections.
Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan JE Jr; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project; National Nosocomial Infections Surveillance (NNIS) System Hospitals. Fridkin SK, et al. Clin Infect Dis. 2001 Aug 1;33(3):324-30. doi: 10.1086/321893. Epub 2001 Jun 21. Clin Infect Dis. 2001. PMID: 11438897
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.
Fridkin SK, Hageman J, McDougal LK, Mohammed J, Jarvis WR, Perl TM, Tenover FC; Vancomycin-Intermediate Staphylococcus aureus Epidemiology Study Group. Fridkin SK, et al. Clin Infect Dis. 2003 Feb 15;36(4):429-39. doi: 10.1086/346207. Epub 2003 Jan 31. Clin Infect Dis. 2003. PMID: 12567300
Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
Whitener CJ, Park SY, Browne FA, Parent LJ, Julian K, Bozdogan B, Appelbaum PC, Chaitram J, Weigel LM, Jernigan J, McDougal LK, Tenover FC, Fridkin SK. Whitener CJ, et al. Among authors: fridkin sk. Clin Infect Dis. 2004 Apr 15;38(8):1049-55. doi: 10.1086/382357. Epub 2004 Mar 24. Clin Infect Dis. 2004. PMID: 15095205
Methicillin-resistant Staphylococcus aureus disease in three communities.
Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Fridkin SK, et al. N Engl J Med. 2005 Apr 7;352(14):1436-44. doi: 10.1056/NEJMoa043252. N Engl J Med. 2005. PMID: 15814879 Free article.
179 results